ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0696

The Mortality Trends Related to SLE in the United States – A 20-year Analysis (2001-to 2020) from the WONDER Database

Ikwinder Preet Kaur1, Harjot Jagdey2, hasan Mirza3, Waqar Mughal4 and Pankaj Bansal5, 1Rutgers/Monmouth Medical Center, Long branch, NJ, 2BronxCare Hospital, Bronx, NY, 3Berkshire Medical Center, Pittsfield, MA, 4DHQ teaching hospital, Gujrat, Pakistan, 5Mayo Clinic, Eau Claire, WI

Meeting: ACR Convergence 2022

Keywords: Mortality, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Epidemiology and Public Health Poster I

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: SLE is an autoimmune rheumatic disease that contributes to increased morbidity and mortality due to multi-organ involvement, infections, and accelerated atherosclerosis leading to cardiovascular diseases. The Centers for Disease Control and Prevention (CDC) reported the worsening trends of SLE deaths from 1979-to 1998 along with gender, age, and race disparities followed by an improvement in mortality thereafter. The literacy level, differences in quality of care, and socioeconomic and environmental factors were proposed explanations for regional/racial mortality differences. The nationwide population-based studies for most recent mortality trends are lacking. We aimed to analyze the temporal trends of SLE-related mortality and review regional, gender, and racial variations across the different United States (US) census regions from 2001-to 2020.

Methods: The underlying cause of death data across the US was retrieved from the CDC’s Wide-Ranging Online Data for Epidemiologic Research (WONDER) database from 2001-to 2020. WONDER database reports the mortality data based on death certificates for US residents. The duration was stratified into five-year periods. The diagnosis of SLE using ICD-10 code M32 was queried among female and male gender without age restrictions. Age-adjusted mortality rate (AAMR) per 100,000 population was calculated for the four US census regions (CR1 Northeast, CR2 Midwest, CR3 South, and CR4 West), and different racial groups.

Results: From 2001-to 2020, a total of 24,552 deaths were attributed to SLE with a decline from 6670 (2001-2005) to 5958 (2016-2020). Overall, AAMR per 100,000 deaths declined by 40% during the study period. The regional AAMR declined by 25% each in the Northeast, Midwest, and West. The maximum decline was observed in the South by 33%. However, overall AAMR remained higher in the South compared to the other census regions (Figure 1). Women had higher Age-Adjusted mortality than men with a downward trajectory reported in all regions; a decline in 50%, 17%, 22%, and 29% in females AAMR in CR1, CR2, CR3, and CR4 respectively over the study duration (Table 1). African Americans had a higher AAMR during these two decades in all census regions than Whites and Asians (Table 2).

Conclusion: This analysis shows an overall and regional decline in deaths from SLE from 2001- to 2020. However, there has been no change in the AAMR in the Northeast and Midwest over the past 15 years, and over the past 10 years in the South and West despite the improvement in therapeutics; a possible explanation can be changing SLE incidence over time. The persistence of geographic, racial, and gender disparities among different census regions, and no decline in mortality in the last 10-15 years are concerning and warrant further investigation. The study limitations include death certificate errors leading to changes in mortality statistics and underreporting SLE as a cause of death.

Supporting image 1

Table 1: SLE related AAMR across the US census regions

Supporting image 2

Table 2: Age-Adjusted Mortality Rate for different races across Northeast, Midwest, South, and West census regions (2001- 2020).

Supporting image 3

Figure 1: SLE related Age-Adjusted Mortality Rate trends


Disclosures: I. Kaur, None; H. Jagdey, None; h. Mirza, None; W. Mughal, None; P. Bansal, None.

To cite this abstract in AMA style:

Kaur I, Jagdey H, Mirza h, Mughal W, Bansal P. The Mortality Trends Related to SLE in the United States – A 20-year Analysis (2001-to 2020) from the WONDER Database [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-mortality-trends-related-to-sle-in-the-united-states-a-20-year-analysis-2001-to-2020-from-the-wonder-database/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-mortality-trends-related-to-sle-in-the-united-states-a-20-year-analysis-2001-to-2020-from-the-wonder-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology